Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

503.82 +1.22 (+0.24%)
Streaming Delayed Price Updated: 10:33 AM EDT, Jul 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 141,857
Open 507.04
Bid (Size) 502.65 (4)
Ask (Size) 503.98 (4)
Prev. Close 502.60
Today's Range 499.06 - 507.80
52wk Range 340.20 - 506.15
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
14 Analysts Assess Vertex Pharmaceuticals: What You Need To Know
Via Benzinga
Vertex Announces FDA Acceptance of New Drug Application for Suzetrigine for the Treatment of Moderate-to-Severe Acute Pain
From Vertex Pharmaceuticals Incorporated
Via Business Wire

Performance

YTD
+22.61%
+22.61%
1 Month
+6.91%
+6.91%
3 Month
+28.26%
+28.26%
6 Month
+12.94%
+12.94%
1 Year
+42.99%
+42.99%

More News

Read More
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?
Via The Motley Fool
The Top 3 Cathie Wood Stocks to Buy Now: Summer 2024
Via InvestorPlace
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
Via Benzinga
Topics Economy
Exposures Interest Rates
Why VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) qualifies as a quality stock.
Via Chartmill
Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals
Via Benzinga
Check Out What Whales Are Doing With VRTX
Via Benzinga
2 No-Brainer Growth Stocks to Buy With $1,000 Right Now
Via The Motley Fool
Is Vertex Pharmaceuticals' Monopoly in Danger?
Via The Motley Fool
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
Via The Motley Fool
7 Biotech Stocks to Keep on Your Clinical Radar
Via InvestorPlace
Here's How Much $100 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today
Via Benzinga
3 Gene Editing Stocks Shaping the Future of Medicine
Via InvestorPlace
2 Historically Flawless Metrics Suggest the Stock Market Can Plunge: Here Are 3 Stocks I've Sold Ahead of What May Be a Big Move for Wall Street
Via The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
Via The Motley Fool
The 3 Best Neuroscience Biotech Stocks to Buy Now
Via InvestorPlace
Looking for growth without the hefty price tag? Consider NASDAQ:VRTX.
Via Chartmill
3 Gene Editing Stocks That Could Grow Your Wealth
Via InvestorPlace
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
Via The Motley Fool
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Via The Motley Fool
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
Via The Motley Fool
Got $1,000? 2 Incredible Growth Stocks to Buy and Hold Forever
Via The Motley Fool
The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024
Via InvestorPlace
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.